Clene Inc. Common Stock
XNAS:CLNN
10.05
$10.40 - 1,358.00
$8.45 - 100.00
$9.21
$10.4
$9.6
$9.56
13.5
2.28
112847
69602.9
7421021.08
Chart
TendieTensor AI Analysis
Company
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Fundamentals
76
-2.730000
-7.658500
-0.85
100
BBG00X3GTK66
BBG00X3GTK84
10.07M
10.07M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CLNN. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.